These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 13627764

  • 1. Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.
    HOLLAND JF, REGELSON W.
    Ann N Y Acad Sci; 1958 Apr 24; 68(3):1122-5. PubMed ID: 13627764
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of melanoma by isolation-perfusion technique.
    CREECH O, RYAN RF, KREMENTZ ET.
    J Am Med Assoc; 1959 Jan 24; 169(4):339-43. PubMed ID: 13610669
    [No Abstract] [Full Text] [Related]

  • 3. Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.
    WESTBURY G, HUMBLE JG, NEWTON KA, SKINNER ME, PEGG DE.
    Lancet; 1959 May 09; 1(7080):968-9. PubMed ID: 13655649
    [No Abstract] [Full Text] [Related]

  • 4. Preliminary clinical trial of p-di-2-chloroethyl-amino-L-phenylalanine (CB 3025, melphalan) and of di-2-chloroethyl methanesulfonate (CB 1506).
    PAPAC R, GALTON DA, TILL M, WILTSHAW E.
    Ann N Y Acad Sci; 1958 Apr 24; 68(3):1126-7. PubMed ID: 13627765
    [No Abstract] [Full Text] [Related]

  • 5. Further observations on the efficacy of phenylalanine mustards against mouse melanoma.
    LUCK JM.
    Cancer Res; 1961 Feb 24; 21():262-4. PubMed ID: 13764029
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of disseminated melanoma with phenylalanine mustard (melphelan) and autogenous bone marrow transplants.
    ARIEL IM, PACK GT.
    Surgery; 1962 May 24; 51():583-91. PubMed ID: 13862259
    [No Abstract] [Full Text] [Related]

  • 7. [A case of malignant melanoma of the leg treated by isolated perfusion of nitrogen mustard].
    MANIZADE D, SALEPCIOGLU A, AKTAN K.
    Turk Tip Cemiy Mecm; 1960 Nov 24; 26():564-9. PubMed ID: 13766186
    [No Abstract] [Full Text] [Related]

  • 8. Nitrogen and phenylalanine mustard. Use in women with intrauterine cancer.
    DIDDLE AW, WATTS G, WATTS J, JENKINS HH.
    Am J Obstet Gynecol; 1962 Feb 15; 83():490-3. PubMed ID: 13886225
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
    DI PIETRO S.
    Minerva Med; 1956 Aug 11; 47(63-64):340-2. PubMed ID: 13378179
    [No Abstract] [Full Text] [Related]

  • 10. Clinical evaluation of CB 1348 in malignant lymphoma and related diseases.
    ISRAELS LG, GALTON DA, TILL M, WILTSHAW E.
    Ann N Y Acad Sci; 1958 Apr 24; 68(3):915-25. PubMed ID: 13627740
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of malignant melanoma by perfusion techniques.
    IRVINE WT, NOON CF.
    Proc R Soc Med; 1961 Jun 24; 54(6):483-5. PubMed ID: 13717903
    [No Abstract] [Full Text] [Related]

  • 12. The effects of a nitrogen mustard derivative of phenylalanine on experimental tumours.
    KOLLER PC, VERONESI U.
    Br J Cancer; 1956 Dec 24; 10(4):703-14. PubMed ID: 13426383
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of malignant lymphoma with chlorambucil (CB 1348, leukeran).
    DE VRIES SI.
    Acta Haematol; 1958 Jan 24; 19(1):1-8. PubMed ID: 13508018
    [No Abstract] [Full Text] [Related]

  • 14. Effect of phenylalanine nitrogen mustard on tissues in culture.
    STUBBLEFIELD E, HSU TC.
    Antibiot Chemother (Northfield); 1957 Sep 24; 7(9):493-6. PubMed ID: 24544534
    [No Abstract] [Full Text] [Related]

  • 15. Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.
    GALTON DA, ISRAELS LG, NABARRO JD, TILL M.
    Br Med J; 1955 Nov 12; 2(4949):1172-6. PubMed ID: 13269823
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of malignant granuloma with nitrogen mustard].
    WISNIEWSKI B.
    Pol Tyg Lek (Wars); 1952 Jun 09; 7(23):752-7. PubMed ID: 12993604
    [No Abstract] [Full Text] [Related]

  • 17. [Role of nitrogen mustard in the treatment of malignant lymphogranuloma].
    CROIZAT P, PAPILLON J, PINET F.
    J Radiol Electrol Arch Electr Medicale; 1953 Jun 09; 34(1-2):83-4. PubMed ID: 13085392
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of malignant systemic affections of the lymphatic tissue with CB 1348].
    DE VRIES SI.
    Ned Tijdschr Geneeskd; 1956 Jul 21; 100(29):2046-53. PubMed ID: 13369613
    [No Abstract] [Full Text] [Related]

  • 19. [Role of nitrogen mustard in the therapy of malignant lymphogranulomatosis].
    CROIZAT P, PAPILLON J, PINET F.
    J Med Lyon; 1952 Oct 20; 33(787):923-6. PubMed ID: 13023229
    [No Abstract] [Full Text] [Related]

  • 20. [About the treatment of malignant tumor by nitrogen-mustard N-oxide [methyl-bis (beta-chloroethyl)-amine-N-oxide hydrochloride].
    OTSUKI K, IWAI Y.
    Gan; 1952 Sep 20; 43(2-3):175-7. PubMed ID: 12998803
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.